首页> 外文期刊>The British journal of general practice: the journal of the Royal College of General Practitioners >Polypharmacy: one of the greatest prescribing challenges in general practice
【24h】

Polypharmacy: one of the greatest prescribing challenges in general practice

机译:多元药房:一般实践中最大的处方挑战之一

获取原文
       

摘要

Pharmaceutical interventions are addressed by a number of papers in this month's issue of the journal. Drug therapy is the major intervention offered by the NHS to enhance and sustain the health of the population. Medicines cost the NHS in excess of £10 billion annually, with the total cost and number of prescriptions steadily rising; the majority of prescribing occurs in general practice. Given this investment, together with the shift of chronic disease management to primary care, GPs need to ensure their prescribing is effective in maximising health gains while minimising risks to patients.
机译:在本月刊上,有关药物干预的文章很多。药物治疗是NHS提供的旨在增强和维持人口健康的主要干预措施。每年,NHS花费的药物费用超过100亿英镑,总费用和处方数量稳步增长;大部分处方都发生在一般实践中。有了这项投资,再加上将慢性病管理转移到基层医疗,全科医生需要确保他们的处方有效地最大程度地提高健康水平,同时最大程度地降低对患者的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号